Aciclovir Other names: Acyclovir

Chemical formula: C₈H₁₁N₅O₃  Molecular mass: 225.205 g/mol  PubChem compound: 135398513

Therapeutic indications

Aciclovir is indicated for:

Herpes simplex virus infection

Population group: only adolescents (12 years - 18 years old) , adults (18 years old or older)

Aciclovir is indicated for the treatment of herpes simplex virus infections of the skin and mucous membranes including initial and recurrent genital herpes (excluding neonatal HSV and severe HSV infections in immunocompromised children).

For this indication, competent medicine agencies globally authorize below treatments (click for details):

Profylaxis of herpesvirus infections in immunocompromised patients

Population group: only adolescents (12 years - 18 years old) , adults (18 years old or older)

Aciclovir is indicated for the prophylaxis of herpes simplex infections and the suppression (prevention of recurrences) of recurrent herpes simplex infections in immunocompetent patients.

For this indication, competent medicine agencies globally authorize below treatments (click for details):

Varicella, herpes zoster

Population group: only adolescents (12 years - 18 years old) , adults (18 years old or older)

Aciclovir is indicated for the treatment of varicella (chickenpox) indicated for the treatment of varicella (chickenpox) and herpes zoster (shingles) infections.

For this indication, competent medicine agencies globally authorize below treatments (click for details):

Varicella, herpes zoster

Population group: only infants (40 days - 1 year old) , children (1 year - 12 years old)

Aciclovir is indicated for the treatment of varicella (chickenpox) indicated for the treatment of varicella (chickenpox) and herpes zoster (shingles) infections.

For this indication, competent medicine agencies globally authorize below treatments (click for details):

Treatment of herpes simplex virus infections

Population group: only children (1 year - 12 years old)

Aciclovir is indicated for the treatment of herpes simplex virus infections of the skin and mucous membranes including initial and recurrent genital herpes (excluding neonatal HSV and severe HSV infections in immunocompromised children).

For this indication, competent medicine agencies globally authorize below treatments (click for details):

Herpetic encephalitis

Population group: only adolescents (12 years - 18 years old) , adults (18 years old or older)

Aciclovir is indicated for the treatment of herpes encephalitis.

For this indication, competent medicine agencies globally authorize below treatments (click for details):

Herpetic encephalitis

Population group: only children (1 year - 12 years old)

Aciclovir is indicated for the treatment of herpes encephalitis.

For this indication, competent medicine agencies globally authorize below treatments (click for details):

Treatment of herpes simplex virus infections

Population group: only newborns (0 - 40 days old) , infants (40 days - 1 year old)

Aciclovir is indicated for the treatment of herpes simplex virus infections of the skin and mucous membranes including initial and recurrent genital herpes (excluding neonatal HSV and severe HSV infections in immunocompromised children).

For this indication, competent medicine agencies globally authorize below treatments (click for details):

Herpes simplex keratitis

Population group: only children (1 year - 12 years old) , adolescents (12 years - 18 years old) , adults (18 years old or older)

Aciclovir is indicated for the treatment of herpes simplex keratitis.

For this indication, competent medicine agencies globally authorize below treatments (click for details):

Profylaxis of herpesvirus infections in immunocompromised patients (children)

Population group: only children (1 year - 12 years old)

at least one of
Herpes simplex
Human herpes simplex virus
and additionally Immunodeficiency

For this indication, competent medicine agencies globally authorize below treatments (click for details):

© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.